Neurothrombectomy Devices Market Size - By Product Type (Stent Retrievers, Aspiration Devices, Snares, Continuous Flush Catheter), End-use (Hospitals, Clinics, Ambulatory Surgical Centers) - Global Forecast (2024-2032)

Neurothrombectomy Devices Market Size - By Product Type (Stent Retrievers, Aspiration Devices, Snares, Continuous Flush Catheter), End-use (Hospitals, Clinics, Ambulatory Surgical Centers) - Global Forecast (2024-2032)

Neurothrombectomy devices market size is projected to register 7.3% CAGR from 2024 to 2032, due to the increasing incidences of ischemic strokes along with the growing aging population. The rising advancements in neurointerventional techniques and the higher emphasis on timely and effective stroke treatment will accelerate the product demand.

Additionally, the rising awareness of the benefits of endovascular procedures is escalating the adoption of minimally invasive techniques. The ongoing R&D activities are leading to the introduction of innovative devices with enhanced safety and efficacy profiles. For instance, in May 2021, Perflow Medical, a medical device company, announced the first successful clinical application of its Stream17 Dynamic Neurothrombectomy Net, specifically engineered to efficiently address patients with more complex anatomies experiencing both hemorrhagic and ischemic strokes. The integration of neurothrombectomy procedures into standard stroke care protocols and improvements in healthcare infrastructure will also boost the industry growth.

The neurothrombectomy devices industry is categorized into product type, end-use, and region.

Based on product type, the industry value from the snares segment is projected to rise at 7.1% CAGR from 2024 to 2032, owing to the increasing adoption for endovascular procedures in stroke treatment. Snares demonstrate efficacy in capturing and removing blood clots, contributing to improved patient outcomes. The increasing advancements in snare technologies will further fuel the product demand to offer enhanced safety and effectiveness.

Neurothrombectomy devices industry share from the ambulatory surgical centers end-use segment is estimated to witness 7.5% CAGR from 2024 to 2032. This is due to the rising preference for minimally invasive neurothrombectomy procedures. Ambulatory surgical centers offer convenience, cost-effectiveness, and shorter recovery times, driving patient and clinician acceptance. Moreover, the growing emphasis on outpatient care will further boost the demand for neurothrombectomy devices in these facilities.

Regionally, the Europe neurothrombectomy devices market is projected to expand at 7.4% CAGR from 2023 to 2032. The growth can be attributed to the increasing incidence of stroke cases, growing aging population, and rapid advancements in neurointerventional techniques. The surging emphasis on improving stroke treatment protocols coupled with healthcare infrastructure developments will drive the regional market growth.